Sign up TODAY and try all premium features FREE for a Month!
Sign Up
Home Mf Research Whiteoak Capital Pharma And Healthcare Fund Regular Plan Growth
WhiteOak Capital Mutual Fund

Whiteoak Capital Pharma and Healthcare Fund - Regular Plan - Growth

Equity Equity Sectoral Thematic
Fund House : WhiteOak Capital Mutual Fund
Overview
Returns
Portfolio
SIP Calculator
Analysis
Peer Comparison
Fund Family
Scheme Details
-
-
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • SI
NAV (as on 2025-06-03)
12.95 -0.04%
Fund Size (Total Assets)
-
Expense Ratio (Regular)
2.37%
Expense Ratio (Direct)
0.65%
SIP Returns
Period Invested for ₹1000 SIP Started on Investments Latest Value Abs. Returns
One Week 2025-05-27 ₹1,000.00 ₹1,000.08
0.01 %
Two Week 2025-05-19 ₹1,000.00 ₹1,003.33
0.33 %
1 Month 2025-05-05 ₹1,000.00 ₹1,001.93
0.19 %
Three Months 2025-03-05 ₹3,000.00 ₹3,126.52
4.22 %
Six Months 2024-12-05 ₹6,000.00 ₹6,042.19
0.70 %
One Year 2024-06-03 ₹12,000.00 ₹12,698.59
5.82 %
Since Inception 2024-01-16 ₹17,000.00 ₹19,038.63
11.99 %
Portfolio Summary
Company Name Sector Sector Type Nav(in %)
Sun Pharmaceutical Industries Limited Pharmaceuticals & Biotechnology Equity 7.02
Cipla Limited Pharmaceuticals & Biotechnology Equity 4.59
Divi's Laboratories Limited Pharmaceuticals & Biotechnology Equity 4.97
Zydus Lifesciences Limited Pharmaceuticals & Biotechnology Equity 5.36
Lupin Limited Pharmaceuticals & Biotechnology Equity 2.30
Torrent Pharmaceuticals Limited Pharmaceuticals & Biotechnology Equity 4.07
Dr. Reddy's Laboratories Limited Pharmaceuticals & Biotechnology Equity 3.40
Aurobindo Pharma Limited Pharmaceuticals & Biotechnology Equity 3.14
Emcure Pharmaceuticals Limited Pharmaceuticals & Biotechnology Equity 3.24
Glenmark Pharmaceuticals Limited Pharmaceuticals & Biotechnology Equity 3.11
Ajanta Pharma Limited Pharmaceuticals & Biotechnology Equity 3.04
Max Healthcare Institute Limited Healthcare Services Equity 2.78
Krishna Institute Of Medical Sciences Limited Healthcare Services Equity 2.66
Neuland Laboratories Limited Pharmaceuticals & Biotechnology Equity 2.66
Poly Medicure Limited Healthcare Equipment & Supplies Equity 2.65
Fortis Healthcare Limited Healthcare Services Equity 2.58
Vijaya Diagnostic Centre Limited Healthcare Services Equity 2.42
Biocon Limited Pharmaceuticals & Biotechnology Equity 2.28
Piramal Pharma Limited Pharmaceuticals & Biotechnology Equity 1.91
Dr. Lal Path Labs Limited Healthcare Services Equity 1.89
Gland Pharma Limited Pharmaceuticals & Biotechnology Equity 1.82
Shilpa Medicare Limited Pharmaceuticals & Biotechnology Equity 1.69
AstraZeneca Pharma India Limited Pharmaceuticals & Biotechnology Equity 1.64
Wockhardt Limited Pharmaceuticals & Biotechnology Equity 1.63
Ami Organics Limited Pharmaceuticals & Biotechnology Equity 1.55
RPG Life Sciences Limited Pharmaceuticals & Biotechnology Equity 1.43
Jupiter Life Line Hospitals Limited Healthcare Services Equity 1.38
Suven Pharmaceuticals Limited Pharmaceuticals & Biotechnology Equity 1.33
FDC Limited Pharmaceuticals & Biotechnology Equity 1.16
Apollo Hospitals Enterprise Limited Healthcare Services Equity 1.11
Supriya Lifescience Limited Pharmaceuticals & Biotechnology Equity 1.08
Granules India Limited Pharmaceuticals & Biotechnology Equity 1.02
Gufic Biosciences Limited Pharmaceuticals & Biotechnology Equity 1.01
Strides Pharma Science Limited Pharmaceuticals & Biotechnology Equity 0.96
Sanofi Consumer Healthcare India Limited Pharmaceuticals & Biotechnology Equity 0.75
Indegene Limited Healthcare Services Equity 0.74
Innova Captab Limited Pharmaceuticals & Biotechnology Equity 0.67
Neogen Chemicals Limited Chemicals & Petrochemicals Equity 0.53
Mankind Pharma Limited Pharmaceuticals & Biotechnology Equity 0.19
Treasury Bill Unknown Debt 2.74
364 Days Sovereign Unknown Debt 1.38
182 Days Sovereign Unknown Debt 1.01
91 Days Sovereign Unknown Debt 0.35
TREPS Unknown Debt 8.31
Net Receivables / (Payables) Unknown Unknown 1.19
SIP Calculator
Risk Ratios
Standard Deviation
-
Beta
-
Sharpe Ratio
-
Lock In Period
-
Residual Maturity
-
Standard Deviation:
Standard deviation numbers measure the variability or volatility of a fund's returns over a specific time period (often 3 years).
  • Low standard deviation = Stable, predictable returns → Suitable for conservative investors seeking stability.
  • High standard deviation = High volatility, more risk → Be cautious, suitable for risk-tolerant investors who can handle fluctuations.
Beta:
Beta measures a fund's volatility about the market or a benchmark. A lower beta means the fund's performance is less sensitive to market movements, making it more predictable compared to the market.
  • Low beta = Less sensitive to market changes → Great for investors with less market exposure.
  • High beta = More sensitive to market changes → Better for aggressive investors who seek higher returns but can handle market risks.
Sharpe Ratio:
The Sharpe Ratio measures how much return a fund has made compared to the risk it carries. A higher Sharpe ratio indicates better returns relative to the risk taken, meaning the fund delivers more efficiently.
  • A higher Sharpe ratio indicates better risk-adjusted returns → Look for funds with higher ratios for better return efficiency.
  • Use it to compare different funds' efficiency in generating returns relative to the risk taken.
Lock-In Period:

India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.

Lock-in times for various investment types

  • Most ELSS mutual fund holders hold for 3 years.
  • Tax savings FDs lock in for 5 years.
  • The lock-in period for 8% Government of India bond investment is 6 years.
  • ULIPs must be locked in for 5 years.
  • The average hedge fund holding period is 30-90 days.
  • The average PPF investor holds onto their money for 15 years.
Residual Maturity:

Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.

There are two different types of residual maturity.

  • Short-term residual maturity: This occurs when a security has less than a year left on its maturity.
  • Long-term residual maturity: This occurs when a security has more than a year left on its remaining maturity.
Scheme Details
  • Fund manager(s) : Mr. Ramesh Mantri (Over 20 Years), Mr. Dheeresh Pathak (Over 16 Years), Mr. Piyush Baranwal (Over 14 Years),
  • Expense ration regular : 2.37
  • Expense ration direct : 0.65
  • Launch date : -
  • Benchmark : -
  • Min SIP amount : -
  • Max SIP amount : -
  • Min investment amount (one time- first time) : ₹100.00
  • Type : equity
Exit load
1.00%

FAQs

Is a Mutual Fund with a Lower NAV Better?
What Are the Charges in Mutual Fund Investments?
What Are the Tax Benefits of Mutual Funds?
Is It a Good Time to Invest in Mutual Funds?
What Is the Difference Between Dividend and Growth Plans?
Should I Invest in Infrastructure Funds?
What Are Sector-Specific Funds/Schemes?
What Happens If I Miss an SIP Payment?
How Can I Compare Different Mutual Funds?